Emergent BioSolutions, Inc. (EBS)
-NYSE 14.40 
0.19(1.34%) 10:15AM EDT - Nasdaq Real Time Price
| Prev Close: | 14.21 |
|---|
| Open: | 14.18 |
|---|
| Bid: | 14.32 x 300 |
|---|
| Ask: | 14.36 x 100 |
|---|
| 1y Target Est: | 20.33 |
|---|
| Beta: | 0.98 |
|---|
| Next Earnings Date: | 29-Jul-13 |
|---|
| Day's Range: | 14.20 - 14.42 |
|---|
| 52wk Range: | 12.50 - 16.99 |
|---|
| Volume: | 7,392 |
|---|
| Avg Vol (3m): | 242,808 |
|---|
| Market Cap: | 520.14M |
|---|
| P/E (ttm): | 23.20 |
|---|
| EPS (ttm): | 0.62 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- July Options Now Available For Emergent BioSolutions (EBS)at TheStreet(Mon, May 20)
- Emergent BioSolutions to Webcast Presentation at Jefferies 2013 Global Healthcare ConferenceBusiness Wire(Mon, May 20)
- Emergent BioSolutions' Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)at Seeking Alpha(Thu, May 16)
- Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 23, 2013 at 9:00 AM Eastern; Webcast Will Be AvailableBusiness Wire(Thu, May 16)
- Biodefense: Live By Government Contracts, Die By Government Contractsat Seeking Alpha(Sun, May 12)
- Emergent Biosolutions Management Presents at Cowen Health Care Conference (Transcript)at Seeking Alpha(Fri, May 10)
- Emergent BioSolutions to Webcast Presentation at Bank of America Merrill Lynch 2013 Health Care ConferenceBusiness Wire(Thu, May 9)
- EMERGENT BIOSOLUTIONS INC. FinancialsEDGAR Online Financials(Wed, May 8)
- 1 Winner and 4 Losers from This Week’s Earnings Stormat Wall St. Cheat Sheet(Sat, May 4)
- Emergent BioSolutions' CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 3)
- Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate CancerBusiness Wire(Fri, May 3)
- EMERGENT BIOSOLUTIONS INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Thu, May 2)
- Emergent BioSolutions Earnings: Here’s Why the Stock is Rising Nowat Wall St. Cheat Sheet(Thu, May 2)
- Emergent BioSolutions Inc. Earnings Call scheduled for 5:00 pm ET todayCCBN(Thu, May 2)
- Emergent BioSolutions Reports Financial Results for First Quarter 2013Business Wire(Thu, May 2)
Key Statistics
| Forward P/E (1 yr): | 15.09 |
|---|
| P/S (ttm): | 1.87 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 0.74 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.21 |
|---|
| Mean Recommendation*: | 1.4 |
|---|
| PEG Ratio (5 yr expected): | 1.95 |
|---|
Business Summary
Emergent BioSolutions, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and commercialization of vaccines and therapeutics for use in defense and commercial markets to healthcare providers and purchasers in the Un...
View More